You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
IGF OT IGF A SHARED DECISION MAKING TOOL TO PREVENT SUBSTANCE ABUSE N DA PERIOD OF PERFORMANCE SEPTEMBER MARCH BASE AWARD
SBC: RINGFUL LLC Topic: NIDANot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF I CLR AS A NEO ADJUVANT TREATMENT OPTION FOR TRIPLE NEGATIVE BREAST CANCER PERIOD OF PERFORMANCE
SBC: Cellectar Biosciences, Inc. Topic: NCIPoor prognosis of triple negative breast cancer TNBC is attributable to the absence of efficacious molecularly targeted neoadjuvant therapies Micrometastases contribute to poor prognosis by increasing recurrence rate Consequently an effective treatment option that is capable of targeting and sterilizing micrometastatic disease in patients with TNBC is warranted I CLR is proposed as ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF IN VITRO CANCER STEM CELL EXPANSION PROGRAM FOR RARE TUMOR TYPES PERIOD OF PERFORMANCE
SBC: KIYATEC, LLC Topic: NCIThe overall objective of this proposal is to develop an in vitro process by which cancer stem cells CSC can be isolated from primary human tumor biopsies or tissues expanded without losing critical elements of stem cell qualities and then used for preclinical and clinical applications During this fast track proposal KIYATEC will employ an integrated functional and unbiased scientific strate ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF EVORX TECHNOLOGIES INC
SBC: EVORX TECHNOLOGIES, INC. Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF SBIR TOPIC
SBC: MODULATION THERAPEUTICS, INC. Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
SBIR PHASE I RADIONUCLIDE THERAPY FOR METASTATIC MELANOMA VIEWPOINT MOLECULAR TARGETING LLC IGF OT IGF
SBC: VIEWPOINT MOLECULAR TARGETING, INC. Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF "SBIR PHASE I NEW D HUBIOGEL CULTURE SYSTEM FOR CANCER STEM CELLS EXPANSION and ANALYSIS"
SBC: Vivo Biosciences Inc Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF DEVELOPMENT OF AN INNOVATIVE PSMA TARGETED RADIONUCLIDE THERAPY FOR PROSTATE CANCER PERIOD OF PERFORMANCE
SBC: Cancer Targeted Technology LLC Topic: NCIBackground Information The Phase II of the contract has four objectives Objective Scale up and analytical characterization of the lead radiotherapeutic agent selected from Phase I Objective Optimization of dose regimen in an animal efficacy model using a PSMA expressing subcutaneous human prostate tumor Objective Maximum Tolerate Dose Study of Lead Lu DOTA PSMA therapeutic agent ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF SBIR PHASE TOPIC
SBC: AKRIVIS TECHNOLOGIES, LLC Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF ANGIOCRINE BIOSCIENCE INC
SBC: Angiocrine Bioscience Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health